Global IVD Market Research Package 2017: 4 Reports Evaluating the $61 Billion Dollar Industry - Research and Markets
DUBLIN, April 18, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "2017 IVD Market Research Bundle (The Worldwide Market for In Vitro Diagnostic Tests, NGS, Companion, US IVD)" report to their offering.
The IVD market is estimated to be nearly 61 billion dollars.
There are a number of drivers of the market that should be watched in 2017. The IVD industry has been the beneficiary of genomic research and unfortunately the march of obesity, diabetes, cancer, cardiac disease and infectious diseases, worldwide.These situations have created demand for highly specific, sensitive and sometimes expensive tests.
This bundle of previously published studies allows decision-makers and researchers to review critical information in order to be prepared for events coming in 2017.
These topics fit together well as the IVD industry integrates next-generation sequencing into clinical diagnostics, reaches for companion opportunities and specifically targets the world's largest healthcare market. The bundle contains the full reports as they were published.
Studies Included:
- The World Market for In Vitro Diagnostics, 10th Edition - Published August 2016
- United States In Vitro Diagnostics Markets - Published July 2016
- Companion Diagnostic Testing Markets - Published April 2016
- Next Generation Sequencing Markets - Published September 2016
Companies Mentioned
- AB SCIEX Pte Ltd
- Abbott Diagnostics
- Affymetrix Inc
- Agilent Technologies
- Alere Inc
- Animas Corporation
- Angle plc
- ApoCell, Inc
- Arkray
- Ascensia Diabetes Care (formerly Bayer Diabetes Care)
- Beckman Coulter, Inc.
- Becton, Dickinson and Company (BD)
- Bigfoot Biomedical
- Biocept, Inc
- Biodesix, Inc
- bioMérieux Inc
- Bio-Rad Laboratories, Inc
- Bruker BioSciences Corporation
- CellaVision AB
- Debiotech SA
- DexCom, Inc
- Diagnostica Stago, S.A.S
- Eiken Chemical Co., Ltd
- EliTech Group S.A.S
- Epic Sciences Inc
- ERBA Mannheim
- Fujirebio Diagnostics, Inc
- Gentag, Inc
- Glytec Inc
- Haemokinesis Pty Ltd
- Hologic, Inc
- iHealth Lab Inc
- Immucor, Inc
- LabCorp, Laboratory Corporation of America
- Lifescan Inc
- Luminex Corporation
- Mindray Medical International Limited
- Myriad Genetics
- Oncascan Limited
- PerkinElmer, Inc. (PE)
- QIAGEN N.V
- Quest Diagnostics
- Roche Diagnostics
- Savanna (formerly Wildcat)
- Siemens Healthcare Diagnostics
- Solana Molecular System
- Tandem Diabetes Care, Inc
- Verily (formerly Google Life Sciences)
- West Medica
For more information about this report visit http://www.researchandmarkets.com/research/5bpzxs/2017_ivd_market
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article